LINX™ Reflux Management System
LINX™ Reflux Management System
The LINX Reflux Management System is a laparoscopic, fundic-sparing anti-reflux procedure indicated for patients diagnosed with Gastroesophageal Reflux Disease (GERD). LINX™ is a flexible ring of small magnets placed around the lower esophageal sphincter (LES)—the strength of the magnets is precisely calibrated to help keep the weak LES closed to prevent reflux.
MEDIA
The LINX Reflux Management System is a laparoscopic, fundic-sparing anti-reflux procedure indicated for patients diagnosed with Gastroesophageal Reflux Disease (GERD). LINX™ is a flexible ring of small magnets placed around the lower esophageal sphincter (LES)—the strength of the magnets is precisely calibrated to help keep the weak LES closed to prevent reflux.
An innovative surgical treatment for GERD clinically shown to produce consistent, lasting results.1-3*
99%
of patients reported no regurgitation 5 years after LINX™ treatment1†
88%
of patients reported no bothersome heartburn after 5 years.1‡
85%
of patients no longer needed PPIs after LINX™ treatment.1§
83%
A 50% or greater reduction in GERD-HRQL score was achieved in 83% of patients.1¶
Features & Benefits
A revolutionary treatment for reflux disease
LINX™ augments the weak sphincter without compressing the esophagus. The dynamic opening and closing of the beads preserves physiological function, allowing patients to belch and vomit.3#
Favorable safety profile
With a low rate of device removals, rare occurrence of device erosions and no migrations seen in clinical trials, the clinical evidence supports LINX as an effective treatment for GERD with a favorable safety profile.1††
Supported by gastroenterological societies
Recent guidelines/practice updates from the ACG and AGA include LINX™ as an effective surgical option for patients with evidence of GERD.5,6
LINX™ is an effective option to treat GERD after Sleeve Gastrectomy
One-year results of a clinical trial of LINX™ in patients with persistent GERD following sleeve gastrectomy include:7
85%
were free from daily PPIs‡‡
81%
were free from moderate-to-severe heartburn8//
92%
were free from moderate-to-severe regurgitation§§
85%
were free from extra-esophageal symptoms¥
LINX™ Improved Quality of Life
A one-year clinical trial evaluated the safety and efficacy of LINX™ in patients who have had prior a laparoscopic sleeve gastrectomy (LSG) procedure. 81% of LINX™ patients reported improved quality of life 12 months after treatment.7## Additionally, no device migrations or erosions were observed within 12 months of LINX™ treatment.7¥¥
Resources
How LINX Works
01:17
Dr. John Lipham - Outcomes in Large Hiatal Hernia Patients
02:37
Additional Resources
MR conditional
Patients with a LINX™ device can undergo a wide range of diagnostic imaging tests, including: X-Ray, ultrasound, PET scan, CT scan, and MRI under certain conditions.9
Updated sizing tool
The LINX Reflux Management System Esophagus Sizing Tool is designed to enable one-handed use and sizing confidence.
Supporting Documentation
Product Support
© Ethicon US, LLC. 2022.
For complete indications, contraindications, warnings, precautions, and adverse reactions, please reference full package insert.
This site is published by Ethicon US, LLC, which is solely responsible for its contents, and is intended for U.S. audiences only.
This site is intended for Healthcare Professionals. If you are a patient, it is important that you discuss information about the benefits and risks of products with your doctor.
Last updated February 20, 2019. The third-party trademarks used herein are trademarks of their respective owners. Data and usage fees may apply. See your carrier for more information.